Top Markets
Coin of the day
DuoGenic StemCells corporation DuoGenic StemCells corporation

DuoGenic StemCells corporation

7607
Rank in Stocks #31256
Duogenic Stemcells Corporation is primarily engaged in the biotechnology and... Duogenic Stemcells Corporation is primarily engaged in the biotechnology and healthcare industries, offering a variety of services. Their core offerings include cell therapy and the development of closed-culture cell systems. The company was established on March 22, 2018, and its main corporate office is situated in Taichung, Taiwan.
Share Price
$0.37681848
Market Cap
$13.81M
Change (1 day)
-0.84%
Change (1 year)
10.95%
Country
TW
Trade DuoGenic StemCells corporation (7607)

Category

Revenue for DuoGenic StemCells corporation (7607)
Revenue in Aug 2026 TTM: 0
According to DuoGenic StemCells corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DuoGenic StemCells corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors